BIIB vs SFB · P/E 21, rev $9.89B vs $6.99B cap
Biogen Inc (BIIB) versus Stifel Financial Corporation 5.20% Senior Notes due 2047 (SFB) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Stifel Financial Corporation 5.20% Senior Notes due 2047 (SFB) is a other company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
SFB does not have a complete income-statement cache yet.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. SFB currently screens at market cap $6.99B.
Not investment advice. Open the BIIB and SFB stock pages for the full models.
Not investment advice.